Table 4. Results of univariate Cox regression analysis for association of disease-specific factors with relapse-free and overall survival.

Characteristic		RFS		OS
		HR (95% CI)	p	HR (95% CI)	p
AML
Disease status at HSCT	CR1	1.0 (reference)	0.76	1.0 (reference)	0.67
	CR2	1.22 (0.66, 2.28)		1.25 (0.63, 2.45)
	PR/refractory	1.35 (0.41, 4.40)		1.57 (0.48, 5.16)
Cytogenetic/ molecular risk	Favorable	1.0 (reference)	0.08	1.0 (reference)	0.25
	Intermediate	5.16 (0.69, 38.37)		4.78 (0.64, 35.65)
	Poor	7.98 (105, 60.39)		5.73 (0.74, 44.25)
Therapy-related AML	No Yes	1.0 (reference) 1.87 (0.86, 4.07)	0.12	1.0 (reference) 1.85 (0.80, 4.25)	0.15
	Yes	1.87 (0.86, 4.07)		1.85 (0.80, 4.25)
ALL
Disease status at HSCT	CR1	1.0 (reference)	0.01	1.0 (reference)	0.06
	Non-CR1	4.56 (1.41, 14.79)		3.51 (0.94, 12.12)
Cytogenetic risk	Standard/good	1.0 (reference)	0.91	1.0 (reference)	0.57
	Poor	1.07 (0.34, 3.37)		1.50 (0.37, 6.01)
BCR-ABL positivity	No	1.0 (reference)	0.48	1.0 (reference)	0.21
	Yes	1.64 (0.42, 6.35)		3.92 (0.47, 32.63)
Elevated WBC count on diagnosis	No	1.0 (reference)	0.56	1.0 (reference)	0.81
	Yes	0.65 (0.16, 2.73)		0.80 (0.13, 4.80)
MDS
Disease status at HSCT	CR	1.0 (reference)	0.22	1.0 (reference)	0.30
	Non-CR	2.49 (0.58, 10.61)		2.15 (0.50, 9.29)
Cytogenetic risk	Good	1.0 (reference)	0.11	1.0 (reference)	0.21
	Intermediate	3.11 (0.97, 9.92)		2.35 (0.71, 7.80)
	Poor/very poor	3.32 (1.02, 10.8)		2.88 (0.87, 9.58)
IPSS-R risk on diagnosis	Very low/low	1.0 (reference)	0.23	1.0 (reference)	0.18
	Intermediate	1.01 (0.28, 3.57)		1.06 (0.25, 4.45)
	High/very high	2.09 (0.67, 6.5)		2.46 (0.68, 8.81)
IPSS-R risk at HSCT	Very low/low	1.0 (reference)	0.06	1.0 (reference)	0.09
	Intermediate	3.63 (1.26, 10.45)		3.71 (1.14, 12.07)
	High/very high	2.39 (0.73, 7.82)		2.89 (0.81, 10.23)